ReBorn is a next-generation body contouring technology developed by Israeli company LightFective and offered by The Global Beauty Group. It uses innovative Power LED technology to provide non-surgical fat reduction treatments. The Power LEDs are a new type of light source that is hundreds of times more powerful than regular LEDs. The ReBorn machine uses this technology to emit a 940nm infrared light, which is effectively absorbed by fat cells located 5mm-14mm under the skin. This causes the temperature of the fat cells to rise to 42-47°C, triggering a process known as apoptosis, or programmed cell death. This approach is used for consistent, comfortable treatments with remarkable clinical results1.
The ReBorn machine's design features four lightweight and ergonomic treatment applicators, each housing a matrix array of 63 Power LEDs in the 940nm infrared range. This design allows for a large treatment spot size and even, targeted heating of fat cells. The machine is engineered with integrated Power LED and cooling technologies, ensuring patients' safety and comfort during the procedure1.
ReBorn's treatment protocol consists of three comfortable 35-minute sessions, spaced 4-8 weeks apart. As the body naturally eliminates the treated fat cells, patients can see results within 6-8 weeks, with optimal results visible after 12 weeks. The machine offers a safe, comfortable, and effective alternative to liposuction, and studies have shown that it achieves an average temperature on targeted fat cells that is 2.4°C higher than leading competitive fat-reduction devices, making its treatments more effective in destroying fat cells1.
The technical specifications of the ReBorn machine include a Power LED light source, 940nm wavelength, continuous wave pulse width, and four applicators each covering a treatment area of 70x50mm. The maximum power output is 196W, with a maximum power density of 1.4W/cm², and each applicator has a life expectancy of 50,000 hours. The machine weighs 40kg and has a full-color touch screen for ease of use1.
Comments